Open AccessChanges in Stereotypical Behavior Following Chlorpromazine Termination: Polypharmacy Effects on Response Class Membership
Author(s) -
Maria G. Valdovinos,
Marisela Aguilar,
Drew Piersma,
Alyssa Wilkinson,
Craig H. Kennedy
Publication year - 2020
Publication title -
advances in neurodevelopmental disorders
Language(s) - English
Resource type - Journals
eISSN - 2366-7532
pISSN - 2366-7540
DOI - 10.1007/s41252-020-00158-7
Subject(s) - stereotypy , psychology , chlorpromazine , discontinuation , autism , dose , autism spectrum disorder , developmental psychology , psychiatry , clinical psychology , pharmacology , medicine , dopamine , amphetamine , neuroscience
A paucity of information exists relating to the possible biological and environmental interactions influencing the occurrence of stereotypical behavior. In particular, there is limited research on the effects of psychotropic medication use on stereotypy presentation in individuals diagnosed with developmental disabilities such as intellectual disability and autism spectrum disorder.